SCYNEXIS, Inc. Appoints Carole Sable, MD, As Chief Medical Officer
2/24/2014 6:44:30 AM
Drug discovery company SCYNEXIS, Inc., today announced that it has appointed infectious disease expert Carole Sable, MD, as Chief Medical Officer. Dr. Sable was most recently a Vice President at Merck & Co., Inc, initially as franchise integrator in Infectious Diseases and more recently as VP, Project Leadership and Management in Neurosciences and Ophthalmology.
Help employers find you! Check out all the jobs and post your resume.
comments powered by